RenovaCare, Inc. (OTCMKTS:RCAR) Sees Significant Drop in Short Interest

RenovaCare, Inc. (OTCMKTS:RCAR) was the target of a large drop in short interest in August. As of August 31st, there was short interest totalling 7,200 shares, a drop of 76.8% from the August 15th total of 31,000 shares. Based on an average daily volume of 40,500 shares, the days-to-cover ratio is currently 0.2 days.

RCAR remained flat at $$1.03 during trading on Wednesday. 66 shares of the company’s stock were exchanged, compared to its average volume of 15,466. The stock has a 50-day simple moving average of $1.55 and a two-hundred day simple moving average of $2.15. The company has a market capitalization of $89.97 million, a P/E ratio of -12.88 and a beta of 2.31. RenovaCare has a twelve month low of $0.70 and a twelve month high of $3.98.

RenovaCare (OTCMKTS:RCAR) last issued its earnings results on Tuesday, August 3rd. The biotechnology company reported ($0.01) EPS for the quarter.

RenovaCare Company Profile

RenovaCare, Inc operates as a development stage company, which focuses on research, development, and commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. Its flagship technology is the CellMist System, which is comprised of a treatment methodology for cell isolation for the regeneration of human skin cells and other tissues; and a solution sprayer device for delivering cells to the treatment area.

Recommended Story: Trade War

Receive News & Ratings for RenovaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RenovaCare and related companies with MarketBeat.com's FREE daily email newsletter.